Works matching DE "EMPAGLIFLOZIN"

Results: 1052
    1

    Capillary Ketone Level and Future Ketoacidosis Risk in Patients With Type 1 Diabetes Using Sodium–Glucose Cotransporter Inhibitors.

    Published in:
    Diabetes Care, 2025, v. 48, n. 6, p. 1016, doi. 10.2337/dc25-0125
    By:
    • Bapat, Priya;
    • Dhaliwal, Sharon;
    • Song, Cimon;
    • Zhang, Yucheng;
    • Scarr, Daniel;
    • Bakhsh, Abdulmohsen;
    • Budhram, Dalton;
    • Verhoeff, Natasha J.;
    • Weisman, Alanna;
    • Fralick, Michael;
    • Ivers, Noah M.;
    • Cherney, David Z.I.;
    • Tomlinson, George;
    • Mumford, Doug;
    • Lovblom, Leif Erik;
    • Perkins, Bruce A.
    Publication type:
    Article
    2

    Empagliflozin in Patients With Type 2 Diabetes Undergoing On-Pump CABG: The POST-CABGDM Randomized Clinical Trial.

    Published in:
    Diabetes Care, 2025, v. 48, n. 6, p. 988, doi. 10.2337/dc24-2807
    By:
    • Pitta, Fabio Grunspun;
    • Lima, Eduardo Gomes;
    • Tavares, Caio Assis Moura;
    • Martins, Eduardo Bello;
    • Rached, Fabiana Hanna;
    • Moreira, Eduardo Martelli;
    • Mioto, Bruno Mahler;
    • Lottenberg, Simão Augusto;
    • Bolta, Paula Mathias Paulino;
    • Justino, Larissa Gonçalves;
    • Favarato, Desiderio;
    • Carvalho, Letícia Neves Solon;
    • Pinesi, Henrique Trombini;
    • Barbosa, Camila Talita Machado;
    • Dallan, Luís Alberto Oliveira;
    • Dallan, Luís Roberto Palma;
    • Barbosa, Marcelo Henrique Moreira;
    • Kalil Filho, Roberto;
    • de Lemos, James A.;
    • Serrano Jr., Carlos Vicente
    Publication type:
    Article
    3
    4
    5
    6
    7
    8
    9
    10

    Empagliflozin does not affect left ventricular diastolic function in patients with type 2 diabetes mellitus and coronary artery disease: insight from the EMPA-HEART CardioLink-6 randomized clinical trial.

    Published in:
    Acta Diabetologica, 2022, v. 59, n. 4, p. 575, doi. 10.1007/s00592-021-01823-6
    By:
    • Rai, Archana;
    • Connelly, Kim A.;
    • Verma, Subodh;
    • Mazer, C. David;
    • Teoh, Hwee;
    • Ng, Ming-Yen;
    • Roifman, Idan;
    • Quan, Adrian;
    • Pourafkari, Marina;
    • Jimenez-Juan, Laura;
    • Ramanan, Venkat;
    • Ge, Yin;
    • Deva, Djeven P.;
    • Yan, Andrew T.
    Publication type:
    Article
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31

    Relation between Blood Pressure Management and Renal Effects of Sodium-Glucose Cotransporter 2 Inhibitors in Diabetic Patients with Chronic Kidney Disease.

    Published in:
    Journal of Diabetes Research, 2019, p. 1, doi. 10.1155/2019/9415313
    By:
    • Kobayashi, Kazuo;
    • Toyoda, Masao;
    • Kaneyama, Noriko;
    • Hatori, Nobuo;
    • Furuki, Takayuki;
    • Sakai, Hiroyuki;
    • Takihata, Masahiro;
    • Umezono, Tomoya;
    • Ito, Shun;
    • Suzuki, Daisuke;
    • Takeda, Hiroshi;
    • Kanamori, Akira;
    • Degawa, Hisakazu;
    • Yamamoto, Hareaki;
    • Machimura, Hideo;
    • Mokubo, Atsuko;
    • Chin, Keiichi;
    • Obana, Mitsuo;
    • Hishiki, Toshimasa;
    • Aoyama, Kouta
    Publication type:
    Article
    32
    33
    34
    35
    36
    37
    38
    39
    40

    Empagliflozin reduces arrhythmogenic effects in rat neonatal and human iPSC-derived cardiomyocytes and improves cytosolic calcium handling at least partially independent of NHE1.

    Published in:
    Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-35944-5
    By:
    • Silva dos Santos, Danúbia;
    • Turaça, Lauro Thiago;
    • Coutinho, Keyla Cristiny da Silva;
    • Barbosa, Raiana Andrade Quintanilha;
    • Polidoro, Juliano Zequini;
    • Kasai-Brunswick, Tais Hanae;
    • Campos de Carvalho, Antonio Carlos;
    • Girardi, Adriana Castello Costa
    Publication type:
    Article
    41
    42
    43
    44
    45
    46
    47
    48
    49

    Empagliflozin Limits Myocardial Infarction in Vivo and Cell Death in Vitro: Role of STAT3, Mitochondria, and Redox Aspects.

    Published in:
    Frontiers in Physiology, 2017, p. 1, doi. 10.3389/fphys.2017.01077
    By:
    • Andreadou, Ioanna;
    • Efentakis, Panagiotis;
    • Balafas, Evangelos;
    • Togliatto, Gabriele;
    • Davos, Constantinos H.;
    • Varela, Aimilia;
    • Dimitriou, Constantinos A.;
    • Nikolaou, Panagiota-Efstathia;
    • Maratou, Eirini;
    • Lambadiari, Vaia;
    • Ikonomidis, Ignatios;
    • Kostomitsopoulos, Nikolaos;
    • Brizzi, Maria F.;
    • Dimitriadis, George;
    • Iliodromitis, Efstathios K.
    Publication type:
    Article
    50